Document is current
Any future updates will be listed below
-
Authors
Courchesne, Eric
Taluja, Vani
Nazari, Sanaz
Aamodt, Caitlin M.
Pierce, Karen
Duan, Kuaikuai
Stophaeros, Sunny
Lopez, Linda
Barnes, Cynthia Carter
Troxel, Jaden
Campbell, Kathleen
Wang, Tianyun
Hoekzema, Kendra
Eichler, Evan E.
Nani, Joao V.
Pontes, Wirla
Sanchez, Sandra Sanchez
Lombardo, Michael V.
de Souza, Janaina S.
Hayashi, Mirian A. F.
Muotri, Alysson R.
-
Funding
Funding for this research was provided by:
National Institute of Deafness and Communication Disorders (1R01DC016385)
Hartwell Foundation
National Institutes of Health (R01MH101221, R01NS123642, 1R01ES033636, NS105969)
Fundação de Amparo à Pesquisa do Estado de São Paulo (2020/01107-7; 2019/13112-8, 2022/03297-3, 2019/09207-3)
HORIZON EUROPE European Research Council (755816)
CAPES-Print (88881.310795/2018-01)
California Institute of Regenerative Medicine (IT1-06571)
- License Information
-
More Information
Article History
Received: 5 December 2023
Accepted: 8 May 2024
First Online: 25 May 2024
Declarations
:
: The authors declare no competing interests.
: A.R.M. is a co-founder and has equity interest in TISMOO, a company dedicated to genetic analysis and human brain organogenesis, focusing on therapeutic applications customized for autism spectrum disorders and other neurological disorders origin genetics. The terms of this arrangement have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies. E.E.E. is a scientific advisory board (SAB) member of Variant Bio, Inc. The other authors have no conflicts of interest to declare.
: This study of brain cortical organoids derived from patient blood samples was reviewed and approved by the UC San Diego Institutional Review Board.
